Seth Fischer H.Z.'s most recent trade in Milestone Pharmaceuticals Inc was a trade of 40,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Milestone Pharmaceuticals Inc | Seth H.Z. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Esperion Therapeutics Inc. | Seth H.Z. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| Esperion Therapeutics Inc. | Seth H.Z. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 33,000 | 61,150 (0%) | 0% | 0 | Common Stock | |
| Milestone Pharmaceuticals Inc | Seth H.Z. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Aug 2024 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Marinus Pharmaceuticals Inc | Seth H.Z. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 10,450 | 10,450 | - | - | Stock Option (Right to Buy) | |
| Marinus Pharmaceuticals Inc | Seth H.Z. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 2,300 | 12,926 (0%) | 0% | 0 | Common Stock | |
| Esperion Therapeutics Inc. | Seth H.Z. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 32,500 | 32,500 | - | - | Stock Option (right to buy) | |
| Esperion Therapeutics Inc. | Seth H.Z. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 23,000 | 28,150 (0%) | 0% | 0 | Common Stock | |
| Marinus Pharmaceuticals Inc | H.Z. Fischer Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 20,900 | 20,900 | - | - | Stock Option (Right to Buy) | |
| Marinus Pharmaceuticals Inc | Seth Fischer H.Z. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 4,600 | 10,626 (0%) | 0% | 0 | Common Stock | |
| Esperion Therapeutics Inc. | Seth H.Z. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 21,000 | 21,000 | - | - | Stock Option (right to buy) | |
| Esperion Therapeutics Inc. | Seth H.Z. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 5,150 | 5,150 (0%) | 0% | 0 | Common Stock | |
| Agile Therapeutics Inc | Seth H.Z. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 1,065 | 1,065 | - | - | Employee Stock Option (Right to Buy) | |
| Agile Therapeutics Inc | Seth H.Z. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 935 | 976 (0%) | 0% | 0 | Common Stock | |
| Milestone Pharmaceuticals Inc | Seth H.Z. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2023 | 42,000 | 42,000 | - | - | Stock Option (right to buy) | |
| Marinus Pharmaceuticals Inc | Seth H.Z. Fischer | Director | Sale of securities on an exchange or to another person at price $ 6.54 per share. | 06 Feb 2023 | 1,018 | 6,026 (0%) | 0% | 6.5 | 6,658 | Common Stock |
| Marinus Pharmaceuticals Inc | Seth H.Z. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 16,200 | 16,200 | - | - | Stock Option (Right to Buy) | |
| Marinus Pharmaceuticals Inc | Seth H.Z. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 3,600 | 7,044 (0%) | 0% | 0 | Common Stock | |
| Agile Therapeutics Inc | Seth H.Z. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 807 | 807 | - | - | Employee Stock Option (Right to Buy) | |
| Agile Therapeutics Inc | Seth H.Z. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 670 | 2,066 (0%) | 0% | 0 | Common Stock | |
| Esperion Therapeutics Inc. | Seth H.Z. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 11,561 | 11,561 | - | - | Stock Option (right to buy | |
| Marinus Pharmaceuticals Inc | Seth H.Z. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 12,375 | 12,375 | - | - | Stock Option (Right to Buy) | |
| Marinus Pharmaceuticals Inc | Seth H.Z. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 2,750 | 3,444 (0%) | 0% | 0 | Common Stock | |
| Agile Therapeutics Inc | Seth H.Z. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 29,905 | 29,905 | - | - | Employee Stock Option (Right to Buy) | |
| Agile Therapeutics Inc | Seth H.Z. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 24,510 | 55,852 (0%) | 0% | 0 | Common Stock | |
| Marinus Pharmaceuticals Inc | Seth H.Z. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 16,500 | 16,500 | - | - | Stock option (right to buy) |